Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry refers to a pseudogene homologous to the mitochondrially encoded NADH dehydrogenase 5 (MT-ND5) gene. Pseudogenes are nonfunctional sequences similar to known genes but typically contain mutations or deletions preventing expression of a functional protein. MT-ND5, the original functional gene, encodes an essential subunit of Complex I (NADH:ubiquinone oxidoreductase) in the mitochondrial electron transport chain, which is vital for ATP synthesis in cells[1][7]. However, the pseudogene variant (as represented by ENSG00000283130) does not produce a functional protein, is not involved in electron transport or cellular respiration, and is not considered a biological target for drugs or therapeutic intervention. Clarification: This target is not a receptor, enzyme, transporter, or other actionable biological molecule; it is a non-functional pseudogene. Structured data collection for genes intended for therapeutic targeting should exclude pseudogenes unless specifically studying regulatory non-coding elements or evolutionary genomics[1][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrially encoded NADH dehydrogenase 5 pseudogene.